These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
5. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888 [TBL] [Abstract][Full Text] [Related]
6. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S; BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169 [TBL] [Abstract][Full Text] [Related]
7. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
8. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257 [TBL] [Abstract][Full Text] [Related]
9. Evaluation and management of atrial fibrillation. Ali S; Hong M; Antezano ES; Mangat I Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):233-44. PubMed ID: 17378769 [TBL] [Abstract][Full Text] [Related]
10. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015. Alamneh EA; Chalmers L; Bereznicki LR Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198 [TBL] [Abstract][Full Text] [Related]
11. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607 [TBL] [Abstract][Full Text] [Related]
12. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study. Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice. Sabir IN; Matthews GD; Huang CL Postgrad Med J; 2013 Jun; 89(1052):346-51. PubMed ID: 23404744 [TBL] [Abstract][Full Text] [Related]
15. Prevention of stroke in patients with atrial fibrillation. Olsson SB; Halperin JL Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916 [TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500 [TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
18. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation. Mtwesi V; Amit G Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330 [TBL] [Abstract][Full Text] [Related]
19. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL; Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665 [TBL] [Abstract][Full Text] [Related]
20. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]